NCT04254016View on ClinicalTrials.gov

Short Term Effects of a Hibiscus Sabdariffa and Stevia Rebaudiana Drink on Cardiac Relaxation and Urinary Albumin Excretion in a Group of Diabetic Type 2 Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

May 1, 2017

Study Completion Date

May 1, 2017

Conditions
Benefits of a Hibiscus Sabdariffa and Stevia Rebaudiana Drink in Patients With Type 2 Diabetes Mellitus Before and After 8 Weeks of add-on Therapy
Interventions
DIETARY_SUPPLEMENT

HIBISTEVER1

During 8 weeks, administration of a Hibiscus-Stevia drink for 8 weeks at a dose of 4 mg / kg / day for Stevia and 4 g / day for Hibiscus. Evaluation will take place the 30th and 60th days.

Trial Locations (1)

Unknown

Yaounde Central Hospital, NAtional Obesity Center, Yaoundé

All Listed Sponsors
lead

Yaounde Central Hospital

OTHER_GOV

NCT04254016 - Short Term Effects of a Hibiscus Sabdariffa and Stevia Rebaudiana Drink on Cardiac Relaxation and Urinary Albumin Excretion in a Group of Diabetic Type 2 Subjects | Biotech Hunter | Biotech Hunter